Il Dong achieved 197.3 BW sales and 7.3% operating income.

Published: 2005-05-04 06:59:00

Updated: 2005-05-04 06:59:00

Il Dong reported on April 29 for the FY2004 business performance (April 1, 2004 to Mar. 31, 2005) at 197.3 billion won of sales, about 15% up from the previous year of 210 billion won and 31,417 million of the operating incomes, 7.3% up from the previous year, largely owing to successful sales of...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK